Почетна › Dijabetes tipa 1 › Вашингтон
Kliničke studije za Dijabetes tipa 1 u državi Вашингтон
21 studija za Dijabetes tipa 1 traži učesnike na lokacijama u državi Вашингтон.
Gradovi u državi Вашингтон
Zvanični tekst studije (na engleskom)
Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes
- Rainier Clinical Research Center, Renton
- Seattle Children's, Seattle
Тражи се учесник
Узраст од 2 до 80 · Оба пола · Ажурирано 13. 11. 2026. · NCT07864168A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- Benaroya Research Institute at Virginia Mason- Site Number : 8400038, Seattle
- MultiCare Mary Bridge Children's Health Center- Site Number : 8400037, Tacoma
Тражи се учесникФаза 3
Узраст од 1 до 25 · Оба пола · Ажурирано 13. 11. 2026. · NCT07088068CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
- Benaroya Research Institute, Seattle
- University of Washington Diabetes Institute, Seattle
Тражи се учесникФаза 1/2
Узраст од 12 до 35 · Оба пола · Ажурирано 12. 11. 2026. · NCT06783309A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
- Seattle Children's Hospital, Seattle
Тражи се учесникФаза 1/2
Узраст од 9 до 20 · Оба пола · Ажурирано 16. 10. 2026. · NCT07061574SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- Benaroya Research Institute at Virginia Mason, Seattle
- Mary Bridge Children's Outpatient Center - Tacoma, Tacoma
Тражи се учесникФаза 2
Узраст од 5 до 40 · Оба пола · Ажурирано 13. 10. 2026. · NCT07187531Type 1 Diabetes Extension Study
- Benaroya Research Institute, Seattle
Тражи се учесникОпсервациона студија
Узраст од 8 до 35 · Оба пола · Ажурирано 18. 9. 2026. · NCT02734277METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
Тражи се учесникФаза 2
Узраст од 18 до 69 · Оба пола · Ажурирано 15. 9. 2026. · NCT07699380Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
- Benaroya Research Institute, Seattle
Тражи се учесникФаза 2
Узраст од 4 до 34 · Оба пола · Ажурирано 9. 9. 2026. · NCT07216391Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
- Benaroya Research Institute, Seattle
Тражи се учесникФаза 2
Узраст од 8 до 45 · Оба пола · Ажурирано 8. 9. 2026. · NCT07142252Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
- University of Washington, Seattle
Тражи се учесник
Узраст од 18 до 65 · Оба пола · Ажурирано 16. 7. 2026. · NCT06880835Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 2. 6. 2026. · NCT05822609Kidney Precision Medicine Project
- University of Washington, Seattle
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 14. 4. 2026. · NCT04334707Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM
- Rainier Clinical Reseach Center, Renton
Тражи се учесник
Узраст од 18 до 65 · Оба пола · Ажурирано 9. 4. 2026. · NCT07296276Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus
- Rainier Clinical Research Center, Renton
Тражи се учесникФаза 2
Узраст од 18 до 50 · Оба пола · Ажурирано 6. 4. 2026. · NCT06964087Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 24. 3. 2026. · NCT06217302Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
Тражи се учесникФаза 3
Узраст од 18 до 49 · Оба пола · Ажурирано 4. 3. 2026. · NCT05819138Achieving Health in Emerging Adults With Diabetes (AHEAD) Program: A Clinical Trial Designed to Understand if Participation in a Clinical Program Developed Specifically to Support Emerging Adults With Type 1 Diabetes Leads to Improved Diabetes Outcomes.
- Seattle Children's, Seattle
Тражи се учесник
Узраст од 16 до 19 · Оба пола · Ажурирано 30. 12. 2025. · NCT07292558EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
- Benaroya Research Institute, Seattle
Тражи се учесникОпсервациона студија
До 70 година · Оба пола · Ажурирано 19. 12. 2025. · NCT03369821InvesT1D: Promoting Adolescent Investment in Diabetes Care
- Seattle Children's, Seattle
Тражи се учесник
Узраст 12 и старији · Оба пола · Ажурирано 16. 12. 2025. · NCT06384911TrialNet Pathway to Prevention of T1D
- Benaroya Research Institute, Seattle
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 2 до 45 · Оба пола · Ажурирано 1. 7. 2025. · NCT00097292MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
- Seattle Children's Hospital, Seattle
Тражи се учесникФаза 1
Узраст од 12 до 25 · Оба пола · Ажурирано 13. 6. 2025. · NCT05065372Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.